A man is worried his home might kill him after claiming black mould in the property hit him with a deadly fungal lung disease ...
Fosmanogepix is under clinical development by Basilea Pharmaceutica and currently in Phase II for Unspecified Fungal Infections.
Matthew Langsworth says he breathed in fungal spores for a decade, alleging that his landlord painted over black mold instead ...
Matthew Langsworth, from Leamington Spa, Warwickshire, warned his landlord of the extensive spores within his property, but ...
Millions of people develop invasive and chronic aspergillosis infections around the world every year, with mortality rates ranging between 30% to 90%. Only three classes of antifungal drugs available ...
Millions of people develop invasive and chronic aspergillosis infections around the world every year, with mortality rates ranging between 30% to 90%. Only three classes of antifungal drugs ...
[42] Physicians dealing with immunodeficient hosts face the issue of optimal management for invasive aspergillosis (IA ... in these difficult-to-treat mold infections. Data must be supported ...
Since the first filing, F2G has completed a phase 2b study in patients with invasive aspergillosis, scedosporiosis, lomentosporiosis, fusariosis, scopulariopsis, and coccidioidomycosis infections ...
which targets invasive aspergillosis; ceftobiprole, which treats bacterial pneumonia; tonabacase for several staphylococcal infections. It markets its products under Cresemba and Zevtera. The company ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
By Dr Silvia ZayadinVeterinarian Last month, I shared tips on what to consider before bringing home a feathery friend. Today, I’m continuing my bird series, this time focusing on how to keep our ...